Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy | 42 | 2025 | 1463 | 2.490 |
Why?
|
| Pregnancy Complications | 12 | 2025 | 197 | 2.470 |
Why?
|
| Gynecology | 3 | 2024 | 22 | 2.130 |
Why?
|
| Obesity | 15 | 2025 | 814 | 2.090 |
Why?
|
| Weight Gain | 11 | 2025 | 156 | 1.690 |
Why?
|
| Diabetes, Gestational | 10 | 2021 | 311 | 1.380 |
Why?
|
| Prenatal Care | 5 | 2020 | 127 | 1.360 |
Why?
|
| Pregnancy Outcome | 11 | 2024 | 158 | 1.350 |
Why?
|
| Menopause | 6 | 2024 | 68 | 1.300 |
Why?
|
| Female | 57 | 2025 | 12396 | 1.290 |
Why?
|
| Humans | 59 | 2025 | 17314 | 1.150 |
Why?
|
| Adult | 38 | 2025 | 7500 | 1.140 |
Why?
|
| Mass Screening | 9 | 2021 | 672 | 1.060 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2023 | 39 | 0.910 |
Why?
|
| Infant, Small for Gestational Age | 5 | 2024 | 54 | 0.890 |
Why?
|
| Obstetrics | 1 | 2024 | 20 | 0.850 |
Why?
|
| Health Services | 3 | 2020 | 110 | 0.830 |
Why?
|
| Internship and Residency | 1 | 2024 | 49 | 0.820 |
Why?
|
| Blood Pressure Determination | 1 | 2023 | 52 | 0.820 |
Why?
|
| Young Adult | 16 | 2025 | 2465 | 0.790 |
Why?
|
| Postpartum Period | 4 | 2013 | 79 | 0.790 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 86 | 0.740 |
Why?
|
| Infant, Newborn | 12 | 2024 | 805 | 0.740 |
Why?
|
| Body Mass Index | 12 | 2025 | 937 | 0.680 |
Why?
|
| Glucose Tolerance Test | 8 | 2021 | 107 | 0.680 |
Why?
|
| Urogenital System | 1 | 2020 | 2 | 0.680 |
Why?
|
| Vulvovaginitis | 1 | 2020 | 3 | 0.680 |
Why?
|
| Urologic Diseases | 1 | 2020 | 7 | 0.670 |
Why?
|
| Insurance Claim Review | 1 | 2020 | 49 | 0.640 |
Why?
|
| Fractures, Bone | 4 | 2012 | 92 | 0.630 |
Why?
|
| Premature Birth | 5 | 2024 | 132 | 0.620 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2020 | 302 | 0.620 |
Why?
|
| Weight Reduction Programs | 2 | 2016 | 49 | 0.610 |
Why?
|
| Medicaid | 2 | 2020 | 189 | 0.610 |
Why?
|
| Fetal Macrosomia | 5 | 2021 | 27 | 0.600 |
Why?
|
| Retrospective Studies | 10 | 2024 | 2415 | 0.590 |
Why?
|
| Blood Glucose | 2 | 2021 | 314 | 0.580 |
Why?
|
| Managed Care Programs | 1 | 2020 | 300 | 0.570 |
Why?
|
| Health Care Costs | 1 | 2020 | 207 | 0.560 |
Why?
|
| Counseling | 2 | 2016 | 174 | 0.560 |
Why?
|
| Primary Health Care | 2 | 2020 | 726 | 0.550 |
Why?
|
| Postnatal Care | 1 | 2016 | 20 | 0.520 |
Why?
|
| Cohort Studies | 13 | 2023 | 2514 | 0.490 |
Why?
|
| Ovariectomy | 3 | 2012 | 9 | 0.490 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 381 | 0.470 |
Why?
|
| Cervical Intraepithelial Neoplasia | 2 | 2011 | 16 | 0.460 |
Why?
|
| Vaginal Smears | 2 | 2011 | 47 | 0.450 |
Why?
|
| Group Processes | 1 | 2014 | 7 | 0.450 |
Why?
|
| United States | 11 | 2025 | 3866 | 0.440 |
Why?
|
| Hospitalization | 1 | 2020 | 804 | 0.440 |
Why?
|
| Weight Loss | 3 | 2025 | 294 | 0.440 |
Why?
|
| Vaccination | 6 | 2024 | 688 | 0.430 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2011 | 131 | 0.400 |
Why?
|
| Insulin | 1 | 2013 | 188 | 0.390 |
Why?
|
| Gestational Age | 7 | 2025 | 112 | 0.390 |
Why?
|
| Exercise Therapy | 2 | 2015 | 72 | 0.380 |
Why?
|
| Menopause, Premature | 1 | 2012 | 3 | 0.380 |
Why?
|
| Carpal Bones | 1 | 2012 | 3 | 0.380 |
Why?
|
| Diet Therapy | 1 | 2012 | 9 | 0.380 |
Why?
|
| Psychotherapy, Group | 1 | 2012 | 20 | 0.380 |
Why?
|
| Guideline Adherence | 1 | 2013 | 149 | 0.380 |
Why?
|
| Papanicolaou Test | 1 | 2011 | 37 | 0.370 |
Why?
|
| Hypoglycemic Agents | 1 | 2013 | 250 | 0.350 |
Why?
|
| Electronic Health Records | 3 | 2025 | 704 | 0.340 |
Why?
|
| Treatment Outcome | 5 | 2020 | 1160 | 0.330 |
Why?
|
| Infant | 7 | 2023 | 1161 | 0.300 |
Why?
|
| Affect | 1 | 2007 | 21 | 0.280 |
Why?
|
| Women's Health | 1 | 2007 | 197 | 0.260 |
Why?
|
| Pregnancy Trimester, First | 2 | 2024 | 41 | 0.260 |
Why?
|
| Middle Aged | 10 | 2024 | 7836 | 0.260 |
Why?
|
| Mental Health | 1 | 2007 | 169 | 0.250 |
Why?
|
| Logistic Models | 4 | 2013 | 879 | 0.250 |
Why?
|
| Adolescent | 10 | 2024 | 3538 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 664 | 0.240 |
Why?
|
| Body Weight | 3 | 2016 | 203 | 0.240 |
Why?
|
| Mothers | 2 | 2016 | 103 | 0.240 |
Why?
|
| Thinness | 4 | 2025 | 31 | 0.240 |
Why?
|
| Preconception Care | 2 | 2016 | 40 | 0.240 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2024 | 151 | 0.240 |
Why?
|
| Washington | 4 | 2020 | 384 | 0.230 |
Why?
|
| Mastitis | 1 | 2024 | 2 | 0.230 |
Why?
|
| Risk Factors | 9 | 2021 | 3258 | 0.230 |
Why?
|
| Community Health Centers | 1 | 2025 | 64 | 0.230 |
Why?
|
| Osteoporosis | 2 | 2011 | 74 | 0.230 |
Why?
|
| International Classification of Diseases | 1 | 2024 | 86 | 0.220 |
Why?
|
| Stillbirth | 1 | 2024 | 29 | 0.220 |
Why?
|
| Quality of Life | 2 | 2023 | 499 | 0.220 |
Why?
|
| Oregon | 3 | 2020 | 170 | 0.210 |
Why?
|
| Curriculum | 1 | 2024 | 36 | 0.210 |
Why?
|
| Infant, Premature | 2 | 2022 | 57 | 0.210 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 452 | 0.210 |
Why?
|
| Organ Size | 2 | 2021 | 16 | 0.210 |
Why?
|
| Diet | 2 | 2016 | 355 | 0.210 |
Why?
|
| Clinical Competence | 1 | 2024 | 90 | 0.210 |
Why?
|
| Precision Medicine | 1 | 2023 | 29 | 0.200 |
Why?
|
| Intra-Abdominal Fat | 1 | 2023 | 14 | 0.200 |
Why?
|
| Prospective Studies | 3 | 2023 | 1226 | 0.200 |
Why?
|
| Adipose Tissue | 1 | 2023 | 65 | 0.200 |
Why?
|
| Lipids | 1 | 2023 | 69 | 0.200 |
Why?
|
| Abortion, Spontaneous | 1 | 2023 | 49 | 0.200 |
Why?
|
| Advisory Committees | 1 | 2023 | 112 | 0.190 |
Why?
|
| Granulosa Cell Tumor | 1 | 2002 | 1 | 0.190 |
Why?
|
| Liver | 1 | 2021 | 34 | 0.180 |
Why?
|
| Ovarian Neoplasms | 1 | 2002 | 52 | 0.180 |
Why?
|
| Odds Ratio | 4 | 2011 | 640 | 0.180 |
Why?
|
| Hip Fractures | 2 | 2012 | 71 | 0.180 |
Why?
|
| Papillomaviridae | 2 | 2011 | 61 | 0.180 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2022 | 109 | 0.180 |
Why?
|
| Aspirin | 1 | 2021 | 63 | 0.180 |
Why?
|
| Pre-Eclampsia | 1 | 2021 | 40 | 0.180 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 64 | 0.180 |
Why?
|
| Cost of Illness | 2 | 2020 | 92 | 0.170 |
Why?
|
| Pregnant Women | 1 | 2021 | 46 | 0.170 |
Why?
|
| Incidence | 3 | 2021 | 1266 | 0.170 |
Why?
|
| Syndrome | 1 | 2020 | 28 | 0.170 |
Why?
|
| Vaccination Coverage | 1 | 2021 | 52 | 0.170 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2002 | 243 | 0.160 |
Why?
|
| Morbidity | 1 | 2020 | 59 | 0.160 |
Why?
|
| Atrophy | 1 | 2019 | 6 | 0.160 |
Why?
|
| Papillomavirus Infections | 2 | 2011 | 142 | 0.160 |
Why?
|
| Prognosis | 2 | 2019 | 603 | 0.160 |
Why?
|
| Attitude | 1 | 2019 | 28 | 0.160 |
Why?
|
| Anxiety | 2 | 2013 | 154 | 0.160 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 17 | 0.150 |
Why?
|
| Glucose Intolerance | 1 | 2019 | 43 | 0.150 |
Why?
|
| Sensitivity and Specificity | 4 | 2014 | 298 | 0.150 |
Why?
|
| Nocturnal Myoclonus Syndrome | 1 | 2008 | 1 | 0.150 |
Why?
|
| Polysomnography | 1 | 2008 | 5 | 0.150 |
Why?
|
| Wrist | 1 | 2008 | 2 | 0.150 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2008 | 8 | 0.150 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 119 | 0.150 |
Why?
|
| Sleep Wake Disorders | 1 | 2008 | 34 | 0.150 |
Why?
|
| Bariatric Surgery | 1 | 2020 | 129 | 0.150 |
Why?
|
| Clinical Protocols | 2 | 2019 | 40 | 0.130 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2016 | 12 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 2 | 2021 | 310 | 0.130 |
Why?
|
| Overweight | 4 | 2024 | 266 | 0.120 |
Why?
|
| Bronchodilator Agents | 1 | 2016 | 22 | 0.120 |
Why?
|
| Pregnancy Trimester, Third | 3 | 2024 | 17 | 0.120 |
Why?
|
| Research Design | 2 | 2019 | 336 | 0.110 |
Why?
|
| Aged | 6 | 2012 | 6084 | 0.110 |
Why?
|
| Pediatric Obesity | 1 | 2016 | 88 | 0.110 |
Why?
|
| Proportional Hazards Models | 3 | 2012 | 701 | 0.110 |
Why?
|
| Cesarean Section, Repeat | 1 | 2014 | 2 | 0.110 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2014 | 3 | 0.110 |
Why?
|
| Pamphlets | 1 | 2014 | 7 | 0.110 |
Why?
|
| Confidence Intervals | 2 | 2014 | 231 | 0.110 |
Why?
|
| Risk Assessment | 3 | 2022 | 1076 | 0.110 |
Why?
|
| Self-Help Groups | 1 | 2014 | 27 | 0.110 |
Why?
|
| Energy Intake | 1 | 2014 | 98 | 0.110 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 168 | 0.110 |
Why?
|
| Aging | 2 | 2005 | 160 | 0.110 |
Why?
|
| Attitude to Health | 1 | 2015 | 147 | 0.110 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2012 | 100 | 0.110 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1993 | 1 | 0.100 |
Why?
|
| Life Style | 1 | 2015 | 316 | 0.100 |
Why?
|
| Infant Care | 1 | 2013 | 7 | 0.100 |
Why?
|
| Pregnancy Trimesters | 2 | 2025 | 29 | 0.100 |
Why?
|
| Depression, Postpartum | 1 | 2013 | 22 | 0.100 |
Why?
|
| Male | 7 | 2023 | 9804 | 0.100 |
Why?
|
| Child Health Services | 1 | 2013 | 105 | 0.100 |
Why?
|
| Asthma | 1 | 2016 | 400 | 0.100 |
Why?
|
| Term Birth | 1 | 2012 | 9 | 0.100 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 19 | 0.090 |
Why?
|
| Anxiety Disorders | 1 | 2013 | 92 | 0.090 |
Why?
|
| Spinal Fractures | 1 | 2012 | 12 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 146 | 0.090 |
Why?
|
| Comorbidity | 2 | 2008 | 560 | 0.090 |
Why?
|
| Remission, Spontaneous | 1 | 2011 | 6 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 114 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2012 | 108 | 0.090 |
Why?
|
| Body Height | 1 | 2012 | 60 | 0.090 |
Why?
|
| World Health Organization | 1 | 2011 | 10 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 312 | 0.090 |
Why?
|
| Models, Biological | 1 | 2011 | 28 | 0.090 |
Why?
|
| Health Maintenance Organizations | 1 | 2013 | 407 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 41 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2011 | 304 | 0.080 |
Why?
|
| Early Detection of Cancer | 2 | 2011 | 529 | 0.080 |
Why?
|
| Depression | 2 | 2008 | 486 | 0.080 |
Why?
|
| Delivery of Health Care | 1 | 2013 | 390 | 0.080 |
Why?
|
| Hot Flashes | 2 | 2006 | 38 | 0.080 |
Why?
|
| Age Factors | 1 | 2011 | 878 | 0.080 |
Why?
|
| Perimenopause | 1 | 2007 | 11 | 0.070 |
Why?
|
| Premenopause | 1 | 2007 | 24 | 0.070 |
Why?
|
| Factor Analysis, Statistical | 1 | 2007 | 36 | 0.070 |
Why?
|
| Causality | 1 | 2007 | 34 | 0.070 |
Why?
|
| Psychometrics | 1 | 2007 | 119 | 0.070 |
Why?
|
| Time Factors | 3 | 2020 | 1039 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2008 | 1925 | 0.060 |
Why?
|
| Lactation | 1 | 2024 | 34 | 0.060 |
Why?
|
| Live Birth | 1 | 2024 | 8 | 0.060 |
Why?
|
| Congenital Abnormalities | 1 | 2024 | 27 | 0.060 |
Why?
|
| Safety-net Providers | 1 | 2025 | 55 | 0.060 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 34 | 0.050 |
Why?
|
| Child | 2 | 2024 | 2403 | 0.050 |
Why?
|
| Consensus | 1 | 2023 | 40 | 0.050 |
Why?
|
| Maternal Age | 1 | 2023 | 74 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 143 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2013 | 1151 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2023 | 72 | 0.050 |
Why?
|
| Delivery, Obstetric | 2 | 2013 | 18 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2023 | 169 | 0.050 |
Why?
|
| Hysterectomy | 1 | 2002 | 29 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2021 | 2 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2021 | 3 | 0.050 |
Why?
|
| Length of Stay | 2 | 2013 | 171 | 0.050 |
Why?
|
| Weaning | 1 | 2021 | 3 | 0.050 |
Why?
|
| Parturition | 1 | 2021 | 8 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2021 | 19 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2016 | 1380 | 0.050 |
Why?
|
| Perinatal Death | 1 | 2021 | 2 | 0.050 |
Why?
|
| Glucose | 1 | 2021 | 31 | 0.050 |
Why?
|
| Postpartum Hemorrhage | 1 | 2021 | 4 | 0.050 |
Why?
|
| Patient Safety | 1 | 2022 | 37 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2024 | 1098 | 0.040 |
Why?
|
| Socioeconomic Factors | 2 | 2013 | 605 | 0.040 |
Why?
|
| Prevalence | 1 | 2022 | 840 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 1280 | 0.040 |
Why?
|
| Bone Density | 2 | 2011 | 94 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 26 | 0.030 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2021 | 535 | 0.030 |
Why?
|
| Diet, Reducing | 1 | 2015 | 22 | 0.030 |
Why?
|
| Trial of Labor | 1 | 2014 | 1 | 0.030 |
Why?
|
| Patient Preference | 1 | 2014 | 49 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2016 | 476 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 1993 | 1 | 0.030 |
Why?
|
| Auditory Threshold | 1 | 1993 | 2 | 0.030 |
Why?
|
| Reaction Time | 1 | 1993 | 3 | 0.030 |
Why?
|
| Electroencephalography | 1 | 1993 | 4 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 1993 | 9 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1993 | 139 | 0.030 |
Why?
|
| Health Behavior | 1 | 2015 | 346 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2013 | 270 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2012 | 33 | 0.020 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2012 | 33 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2011 | 10 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2012 | 161 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 384 | 0.020 |
Why?
|
| Perinatal Mortality | 1 | 2008 | 3 | 0.020 |
Why?
|
| Maternal Mortality | 1 | 2008 | 3 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2008 | 76 | 0.020 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2006 | 2 | 0.020 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2006 | 2 | 0.020 |
Why?
|
| Trifolium | 1 | 2006 | 2 | 0.020 |
Why?
|
| Clonidine | 1 | 2006 | 3 | 0.020 |
Why?
|
| Soybeans | 1 | 2006 | 4 | 0.020 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2006 | 4 | 0.020 |
Why?
|
| Amines | 1 | 2006 | 5 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2006 | 5 | 0.020 |
Why?
|
| Isoflavones | 1 | 2006 | 14 | 0.020 |
Why?
|
| Plant Extracts | 1 | 2006 | 14 | 0.020 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2006 | 46 | 0.020 |
Why?
|
| Ovary | 1 | 2005 | 5 | 0.010 |
Why?
|
| Testosterone | 1 | 2004 | 22 | 0.010 |
Why?
|
| Estradiol | 1 | 2004 | 23 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2006 | 142 | 0.010 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2004 | 42 | 0.010 |
Why?
|
| Research | 1 | 2005 | 61 | 0.010 |
Why?
|
| Postmenopause | 1 | 2004 | 248 | 0.010 |
Why?
|
| Risk | 1 | 2004 | 496 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 535 | 0.010 |
Why?
|
Concepts
(262)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->